JP2010516747A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516747A5
JP2010516747A5 JP2009546785A JP2009546785A JP2010516747A5 JP 2010516747 A5 JP2010516747 A5 JP 2010516747A5 JP 2009546785 A JP2009546785 A JP 2009546785A JP 2009546785 A JP2009546785 A JP 2009546785A JP 2010516747 A5 JP2010516747 A5 JP 2010516747A5
Authority
JP
Japan
Prior art keywords
human
mrp2
protein
ige
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009546785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516747A (ja
Filing date
Publication date
Priority claimed from FI20075059A external-priority patent/FI20075059A0/fi
Priority claimed from FI20075707A external-priority patent/FI20075707A0/fi
Application filed filed Critical
Priority claimed from PCT/FI2008/050027 external-priority patent/WO2008092993A1/en
Publication of JP2010516747A publication Critical patent/JP2010516747A/ja
Publication of JP2010516747A5 publication Critical patent/JP2010516747A5/ja
Pending legal-status Critical Current

Links

Images

JP2009546785A 2007-01-29 2008-01-29 ＩｇＥを主成分とする新規試薬の製造方法 Pending JP2010516747A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FI20075059A FI20075059A0 (fi) 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus
US88786207P 2007-02-02 2007-02-02
US97788107P 2007-10-05 2007-10-05
FI20075707A FI20075707A0 (fi) 2007-10-05 2007-10-05 Menetelmä uusien IgE-pohjaisten reagenssien valmistamiseksi
PCT/FI2008/050027 WO2008092993A1 (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents

Publications (2)

Publication Number Publication Date
JP2010516747A JP2010516747A (ja) 2010-05-20
JP2010516747A5 true JP2010516747A5 (https=) 2011-02-24

Family

ID=39673692

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009546785A Pending JP2010516747A (ja) 2007-01-29 2008-01-29 ＩｇＥを主成分とする新規試薬の製造方法

Country Status (7)

Country Link
US (1) US20100311604A1 (https=)
EP (1) EP2115139B8 (https=)
JP (1) JP2010516747A (https=)
AU (1) AU2008211807B2 (https=)
CA (1) CA2676843A1 (https=)
NZ (1) NZ577858A (https=)
WO (1) WO2008092993A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011156734A2 (en) 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
WO2011156763A1 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Methods for characterizing kidney function
JP5823031B2 (ja) 2011-06-10 2015-11-25 日立化成株式会社 小胞捕捉デバイスおよびそれを用いるための方法
WO2014003008A1 (ja) 2012-06-28 2014-01-03 国立大学法人広島大学 ヒト汗中に含まれる新規ヒスタミン遊離物質
JP6385005B2 (ja) 2012-08-17 2018-09-05 国立大学法人広島大学 汗アレルギー抗原蛋白質に結合するモノクローナルＩｇＥ抗体
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
EP2820947A1 (en) * 2013-07-05 2015-01-07 B Cell Design Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
EP3218521B1 (en) 2014-11-12 2019-12-25 Hitachi Chemical Co., Ltd. Method for diagnosing organ injury
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
US10537633B2 (en) 2016-03-04 2020-01-21 Jn Biosciences Llc Antibodies to TIGIT
US20190389958A1 (en) * 2017-01-31 2019-12-26 Msm Protein Technologies, Inc. Anti-cxcr4 antibodies
MX2022015157A (es) 2020-06-02 2023-01-16 Arcus Biosciences Inc Anticuerpos para tigit.
CN119626432B (zh) * 2025-02-17 2025-05-27 杭州艾替捷英科技有限公司 针对宠物过敏源检测结果大数据的云架构聚类管理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
US6063621A (en) * 1992-10-27 2000-05-16 Queen's University At Kingston Antibodies to a multidrug resistance protein
ZA966075B (en) * 1995-07-27 1998-01-19 Genentech Inc Protein formulation.
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
FI112501B (fi) * 2001-05-18 2003-12-15 Valtion Teknillinen Heveiiniä sitovat monoklonaaliset vasta-aineet
US7438907B2 (en) * 2002-11-15 2008-10-21 Genmab A/S Human monoclonal antibodies against CD25
JP2005024245A (ja) * 2003-03-25 2005-01-27 Rikogaku Shinkokai Ａｂｃタンパク質と相互作用する物質のスクリーニング方法
US7514534B2 (en) * 2003-11-19 2009-04-07 Dyax Corp. Metalloproteinase-binding proteins

Similar Documents

Publication Publication Date Title
JP2010516747A5 (https=)
JP6900354B2 (ja) 癌治療のための二重特異性ｈｅｒ２リガンド
AU2008211807B2 (en) Method for producing novel IgE based reagents
Pavlickova et al. Advances in recombinant antibody microarrays
CN105980407B (zh) 单克隆抗tk1抗体
Wu et al. Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules
JP7695881B2 (ja) 操作されたｃｄ２５ポリペプチドおよびその使用
DK2114996T3 (en) A process for the preparation of hypo allergens
JP2021193374A (ja) リン酸化アルファ−シヌクレインを検出するための方法
JP2007526233A5 (https=)
Ebrahimizadeh et al. Production of novel VHH nanobody inhibiting angiogenesis by targeting binding site of VEGF
CN106164672B (zh) 用于诊断的细胞表面前列腺癌抗原
Geng et al. Structure-based design of peptides with high affinity and specificity to HER2 positive tumors
Shukla et al. Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies
WO2022152185A1 (zh) 靶向cd5的全人源抗体
Figini et al. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor
JP2024504903A5 (https=)
Murray et al. Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2
TWI454275B (zh) Ｔ細胞之死亡誘導表位
Domina et al. Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries
Zahid et al. Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential
US20220162341A1 (en) Methods of using monoclonal antibodies targeting epitopes of asph
Huang et al. A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes
Ballard et al. Quantitative PCR-based approach for rapid phage display analysis: a foundation for high throughput vascular proteomic profiling
AU2015252024B2 (en) Haptens, hapten conjugates, compositions thereof and method for their preparation and use